Study protocol of the TRICOLORE trial: a randomized phase III study of oxaliplatin-based chemotherapy versus combination chemotherapy with S-1, irinotecan, and bevacizumab as first-line therapy for metastatic colorectal cancer

BACKGROUND: Metastatic colorectal cancer carries a poor prognosis and cannot be cured by currently available therapy. Chemotherapy designed to prolong survival and improve the quality of life (QOL) of patients is the mainstay of treatment. Standard regimens of FOLFOX/bevacizumab and CapeOX/bevacizum...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Komatsu, Yoshito, Ishioka, Chikashi, Shimada, Ken, Yamada, Yasuhide, Gamoh, Makio, Sato, Atsushi, Yamaguchi, Tatsuro, Yuki, Satoshi, Morita, Satoshi, Takahashi, Shin, Goto, Rei, Kurihara, Minoru
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4565014/
https://ncbi.nlm.nih.gov/pubmed/26353772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1630-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados